Department of Anesthesiology, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, China.
Department of Anesthesiology, Beijing Stomatological Hospital, Capital Medical University, Beijing, 100070, China.
BMC Anesthesiol. 2024 Nov 28;24(1):441. doi: 10.1186/s12871-024-02822-0.
Effective postoperative pain management is critical for pediatric craniotomies. Scalp nerve block (SNB) interventions present a potential solution, yet their comparative benefits in preoperative and postoperative settings remain unclear. This study investigated the analgesic effects of SNB in pediatric craniotomy patients by comparing preoperative versus postoperative administration.
This randomized trial included 180 children (1-12 years) who underwent elective craniotomy and were assigned to the preoperative, postoperative, or nonblocking control group. The outcomes included cumulative sufentanil use, pain scores (1, 2, 4, 24, 48 h postoperation), rescue medicine utilization, postoperative complications (24, 48 h), and hospitalization length. The primary outcome was total sufentanil use within 24 h postsurgery.
Total sufentanil use (µg·kg) in the postoperative block group was significantly lower than that in the nonblocking control group at 1 h (P < 0.001, 95% CI [-0.024 to -0.006]), 2 h (P < 0.001, 95% CI [-0.054 to -0.020]), 4 h (P < 0.001, 95% CI [-0.089 to -0.032]), 24 h (P < 0.001, 95% CI [-0.192 to -0.047]), and 48 h (P = 0.010, 95% CI [-0.208 to -0.022]) postoperation. Additionally, sufentanil use in the preoperative block group was significantly lower than that in the nonblocking control group at 1 h (P = 0.004, 95% CI [-0.021 to -0.003]), 2 h (P < 0.001, 95% CI [-0.043 to -0.010]), and 4 h (P = 0.002, 95% CI [-0.069 to -0.013]). Within 24 h postoperation, the use of sufentanil in the postoperative block group was significantly lower than that in the preoperative block group (P = 0.014, 95% CI [-0.157 to -0.013]).
Compared with preoperative SNB or nonblocking, postoperative SNB significantly reduces postoperative sufentanil use within 24 h for pediatric patients undergoing craniotomy, highlighting its potential as an effective analgesic intervention in this population.
The trial was registered at the Chinese Clinical Trial Registry (ChiCTR1800017386) on 27/07/2018, under the title "A study of scalp nerve block for neurosurgical analgesia in children with craniotomy."
有效的术后疼痛管理对小儿颅切除术至关重要。头皮神经阻滞(SNB)干预措施提供了一种潜在的解决方案,但它们在术前和术后环境中的比较益处仍不清楚。本研究通过比较术前与术后给药,调查了 SNB 在小儿颅切除术患者中的镇痛效果。
本随机试验纳入了 180 名(1-12 岁)接受择期颅切除术的儿童,并分为术前、术后或非阻滞对照组。结果包括累积舒芬太尼使用量、疼痛评分(术后 1、2、4、24、48 小时)、急救药物使用、术后并发症(术后 24、48 小时)和住院时间。主要结局是术后 24 小时内舒芬太尼的总使用量。
与非阻滞对照组相比,术后阻滞组在 1 小时(P < 0.001,95%CI [-0.024 至 -0.006])、2 小时(P < 0.001,95%CI [-0.054 至 -0.020])、4 小时(P < 0.001,95%CI [-0.089 至 -0.032])、24 小时(P < 0.001,95%CI [-0.192 至 -0.047])和 48 小时(P = 0.010,95%CI [-0.208 至 -0.022])时舒芬太尼的使用量显著降低。此外,与非阻滞对照组相比,术前阻滞组在 1 小时(P = 0.004,95%CI [-0.021 至 -0.003])、2 小时(P < 0.001,95%CI [-0.043 至 -0.010])和 4 小时(P = 0.002,95%CI [-0.069 至 -0.013])时舒芬太尼的使用量显著降低。在术后 24 小时内,术后阻滞组舒芬太尼的使用量明显低于术前阻滞组(P = 0.014,95%CI [-0.157 至 -0.013])。
与术前 SNB 或非阻滞相比,术后 SNB 可显著减少小儿颅切除术患者术后 24 小时内舒芬太尼的使用量,这表明其作为小儿人群中一种有效的镇痛干预措施具有潜力。
该试验于 2018 年 7 月 27 日在中国临床试验注册中心(ChiCTR1800017386)注册,标题为“头皮神经阻滞在儿童颅切除术神经外科镇痛中的研究”。